DePuy Orthopaedics acquires BioMedical Enterprises: 6 things to know

Spinal Tech

DePuy Orthopaedics, part of the DePuy Synthes Companies of Johnson & Johnson, acquired BioMedical Enterprises.

Here are six things to know:

 

1. BioMedical Enterprises manufactures Nitinol orthopedic implants for small bone fixation. Nitinol is a nickel-titanium alloy that provides dynamic continuous active compression.

 

2. The implants are indicated for treatment of bunions, hammertoes and other foot and ankle deformities as well as hand and wrist deformities.

 

3. The implants come ready-to-use on a sterilized, pre-loaded, disposable insertion tool.

 

4. The acquisition reinforces Johnson & Johnson Medical Device's focus on strengthening DePuy Synthes' portfolio for elective extremity procedures.

 

5. DePuy Synthes focuses on the foot and ankle as well as hand and wrist markets for bone fixation in trauma.

 

6. England Securities, LLC represented the seller, BioMedical Enterprises, in the transaction.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers